[M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
 and Adhesion in Small Cell Lung Cancer]

Wenting Wu1, Shuxiang Zhang2, Caihong Hu1

  • 1Ningxia Medical University Yinchuan 750004, China.

Abstract

Insights

Muscarinic receptor 3 (M3R) is present in small cell lung cancer (SCLC) cells. Blocking M3R with an antagonist inhibits SCLC cell proliferation and adhesion while promoting apoptosis, suggesting a therapeutic target for SCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Muscarinic receptors 3 (M3R) are implicated in cancer development and progression.
  • Understanding M3R's role in small cell lung cancer (SCLC) is crucial for targeted therapies.

Purpose of the Study:

  • To investigate M3R expression in the human SCLC cell line SBC3.
  • To explore the effects of an M3R antagonist on SBC3 cell proliferation, apoptosis, and adhesion.

Main Methods:

  • M3R expression was analyzed using RT-PCR and Western blot in SBC3 cells.
  • Cell proliferation and apoptosis were assessed using MTT assays and flow cytometry.
  • Cell adhesion was evaluated using fibronectin-coated plates after treatment with M3R antagonist (4-DAMP) and acetylcholine.

Main Results:

  • M3R was detected in SBC3 cells.
  • The M3R antagonist 4-DAMP dose-dependently inhibited cell proliferation and promoted apoptosis.
  • 4-DAMP abrogated acetylcholine-induced cell adhesion to fibronectin, mediated by αvβ1 and α5β1 integrins, without altering integrin expression.

Conclusions:

  • M3R is expressed in SCLC cells (SBC3).
  • M3R antagonism suppresses SCLC cell proliferation and adhesion while enhancing apoptosis.
  • The inhibitory effect on adhesion involves functional modulation of β1-containing integrins, not changes in their expression.

Related Concept Videos

Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.9K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.0K